Back to top

Point-of-Care Diagnosis

​Single-patient assays at the point-of-care

The NALIA single-patient point-of-care device requires only a pin-prick of blood for use in doctors' offices and clinics, expediting patient diagnosis without increasing healthcare costs.

Point-of-Care Diagnosis

NALIA is developing products for use in diagnosis and monitoring in several major disease areas, including:

  • Allergies
  • Autoimmune diseases (including Lupus and Rheumatoid Arthritis)
  • Infectious diseases
  • Oncology

NALIA proprietary Array technology has two advantages that previously prevented ELISA-type assays from being performed at the point-of-care:

Lab in a cartridge – Unlike standard ELISAs, which require multiple pipetting steps, NALIA technology can be transferred into a small, automated cartridge.

Rapid results – Results can be obtained in less than 20 minutes (standard ELISAs require 1.5-2 hours) and this time will be further shortened in a next-generation system.